Atlantic Lithium Limited — Director's Dealing 2024

Apr 7, 2024

8 April 2024

Notices of Changes to Directors’ Interests

Atlan�c Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, “Atlan�c Lithium” or the “Company”), the African-focused lithium explora�on and development company targe�ng to deliver Ghana’s first lithium mine, provides no�ce of changes to directors’ interests in accordance with lis�ng rule 3.19A.2, and as agent for the following director for the purposes of sec�on 205G of the Corpora�ons Act 2001 (Cth):

• Neil Herbert

No�ce for the director is atached to this announcement.

Following the share purchase, Directors and key management personnel (“KMP”) of the Company have purchased a total of 10,152,227 shares equa�ng to a value of A$5,192,393 (£2,794,015) in the last 13 months.

Authorised for release by Amanda Harsas, Finance Director and Company Secretary, Atlan�c Lithium Limited.

For any further informa�on, please contact:

Atlan�c Lithium Limited

Neil Herbert (Execu�ve Chairman)

Amanda Harsas (Finance Director and Company Secretary)

[www.atlan�clithium.com.au ]

IR@atlan�clithium.com.au

Tel: +61 2 8072 0640

==> picture [126 x 4] intentionally omitted <==

• ,

8 April 2024

==> picture [90 x 21] intentionally omitted <==

==> picture [114 x 33] intentionally omitted <==

SP Angel Corporate Finance LLP Nominated Adviser Jeff Kea�ng Charlie Bouverat Tel: +44 (0)20 3470 0470

==> picture [69 x 44] intentionally omitted <==

Yellow Jersey PR Limited Charles Goodwin Bessie Elliot atlan�c@yellowjerseypr.com Tel: +44 (0)20 3004 9512

==> picture [69 x 44] intentionally omitted <==

Canaccord Genuity Limited Financial Adviser: Raj Khatri (UK) / Duncan St John, Chris�an Calabrese (Australia)

Corporate Broking: James Asensio Tel: +44 (0) 20 7523 4500

Notes to Editors:

About Atlan�c Lithium

www.atlan�clithium.com.au

a significant lithium spodumene pegma�te discovery in Ghana, through to produc�on to become the country’s first lithium-producing mine.

year mine life, making it one of the largest spodumene concentrate mines in the world.

The Project, which was awarded a Mining Lease in October 2023, is being developed under an earn-in agreement with Piedmont Lithium Inc.

Atlan�c Lithium holds a por�olio of lithium projects within 509km[2] and 774km[2] of granted and under-applica�on tenure across Ghana and Côte d'Ivoire respec�vely, which, in addi�on to the Project, comprises significantly underexplored, highly prospec�ve licences.

==> picture [524 x 6] intentionally omitted <==

No�ces of Changes to Directors’ Interests

Page 2 of 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Atlantic Lithium Limited

ABN: 17 127 215 132

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Neil Herbert
Date of last notice	29 December 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Securities registered in the name of Cambrian Limited
Date of change	5 April 2024

• See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	7,973,305 Ordinary Shares 2,000,000 Options exercise price £0.60 expiry on 31 March 2025 3,000,000 Options exercise price £0.70 expiry on 23 April 2024 3,000,000 Options exercise price £0.75 expiry on 23 April 2024 2,000,000 Options exercise price £0.80 expiry on 23 April 2024 1,117,247 Performance Rights with a vesting date 31 July 2024 1,117,247 Performance Rights with a vesting date 31 July 2025 1,263,349 Performance Rights with a vesting date 31 July 2026
Class	Ordinary Shares
Number acquired	133,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	A$47,590 (£24,771)

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

8,106,305 Ordinary Shares 2,000,000 Options exercise price £0.60 expiry on 31 March 2025 3,000,000 Options exercise price £0.70 expiry on 23 April 2024 3,000,000 Options exercise price £0.75 expiry on 23 April 2024 2,000,000 Options exercise price £0.80 expiry on 23 April 2024 1,117,247 Performance Rights with a vesting date 31 July 2024 1,117,247 Performance Rights with a vesting date 31 July 2025 1,263,349 Performance Rights with a vesting date 31 July 2026

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 – +Closed period

Part 3 – +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011